Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	203.9	426.1	678.9	116.6	107.1	223.6
Short-Term Investments	-	8.1	9.9	9.5	24.8	12.7
Cash & Short-Term Investments	204.2	434.2	688.8	126.1	131.9	236.3
Cash Growth	-70.95%	-36.96%	446.23%	-4.40%	-44.18%	239.49%
Accounts Receivable	273.2	192.8	265.9	293.7	404.6	356
Other Receivables	82.1	31.5	33.8	39.8	14	14.7
Receivables	355.3	227.3	300.6	334.4	419.7	371.7
Inventory	714.3	690.9	684.9	882.4	1,025	783
Other Current Assets	78.8	88.8	66.7	72.2	94.8	64.6
Total Current Assets	1,353	1,441	1,741	1,415	1,671	1,456
Property, Plant & Equipment	2,064	1,431	1,163	1,036	808	640.2
Long-Term Investments	20.5	19	24	40.8	24.9	14.8
Goodwill	2,894	2,884	2,908	2,885	1,136	820.7
Other Intangible Assets	1,500	1,231	1,361	1,465	712.1	563.3
Long-Term Deferred Tax Assets	82.8	75.2	63.2	60	61.6	46.5
Long-Term Deferred Charges	-	303.8	269	227.8	164.2	120.9
Other Long-Term Assets	3.2	598.7	727.6	601	487	289.1
Total Assets	7,918	7,984	8,256	7,730	5,065	3,951

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	288.8	277.8	310	258.5	251.5	251.4
Accrued Expenses	90.5	99.1	88.2	62.3	74.1	97.2
Current Portion of Long-Term Debt	289.9	557.3	39.5	57.7	4.5	25.5
Current Portion of Leases	24.9	23.4	25	21.4	19.5	14.9
Current Income Taxes Payable	117.1	82	123.2	189.4	209.6	165
Current Unearned Revenue	182.8	167.6	216.1	238.6	271	259.6
Other Current Liabilities	172.4	204.9	136.8	109.4	205.7	223.5
Total Current Liabilities	1,166	1,412	938.8	937.3	1,036	1,037
Long-Term Debt	1,942	1,867	2,684	3,510	1,021	521.1
Long-Term Leases	146.1	151.2	120.6	93.1	91.1	64
Pension & Post-Retirement Benefits	33.2	38.8	39.3	34.6	35.6	46.8
Long-Term Deferred Tax Liabilities	362.5	375.6	358.2	389.4	178.3	125.8
Other Long-Term Liabilities	20.7	12.9	91.3	92.2	189.7	423
Total Liabilities	3,671	3,858	4,233	5,056	2,551	2,218

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	19.5	19.5	19.5	18.4	18.4	18.4
Retained Earnings	2,842	2,703	2,496	2,391	2,179	1,397
Comprehensive Income & Other	-48.8	1,368	1,471	229	251.9	240.2
Total Common Equity	4,237	4,091	3,987	2,639	2,449	1,656
Minority Interest	10	35.6	37.2	35.3	64.9	77.4
Shareholders' Equity	4,247	4,126	4,024	2,674	2,514	1,733
Total Liabilities & Equity	7,918	7,984	8,256	7,730	5,065	3,951

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,403	2,599	2,870	3,682	1,136	625.5
Net Cash (Debt)	-2,198	-2,165	-2,181	-3,556	-1,004	-389.2
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-22.61	-22.25	-22.53	-38.58	-10.89	-4.22
Filing Date Shares Outstanding	96.88	97.3	97.3	92.16	92.16	92.18
Total Common Shares Outstanding	96.88	97.3	97.3	92.16	92.16	92.18
Working Capital	186.2	29.1	802.2	477.8	635.3	418.5
Book Value Per Share	43.74	42.04	40.97	28.63	26.58	17.96
Tangible Book Value	-157.2	-24.7	-282.4	-1,711	600.8	271.9
Tangible Book Value Per Share	-1.62	-0.25	-2.90	-18.57	6.52	2.95
Land	-	1,023	803.1	707.8	509.1	426.2
Machinery	-	895.6	796.2	688.5	581.3	469.7
Order Backlog	-	1,308	1,482	1,495	1,844	1,915

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error